Marco Filetti
Title
Cited by
Cited by
Year
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
A Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...
Journal for immunotherapy of cancer 7 (1), 1-11, 2019
1132019
The psychophysiology primer: a guide to methods and a broad review with a focus on human-computer interaction
BU Cowley, M Filetti, K Lukander, J Torniainen, A Helenius, L Ahonen, ...
Foundations and Trends in Human-Computer Interaction, 2016
812016
Clinical outcomes of patients with advanced cancer and pre‐existing autoimmune diseases treated with anti‐programmed death‐1 immunotherapy: A real‐world transverse study
A Cortellini, S Buti, D Santini, F Perrone, R Giusti, M Tiseo, M Bersanelli, ...
The oncologist 24 (6), e327, 2019
522019
Subliminal Salience Search Illustrated: EEG Identity and Deception Detection on the Fringe of Awareness
H Bowman, M Filetti, D Janssen, L Su, A Alsufyani, B Wyble
PLOS One 8 (1), e54258, 2013
442013
Correlations between the immune-related adverse events spectrum and efficacy of anti-PD1 immunotherapy in NSCLC patients
A Cortellini, R Chiari, B Ricciuti, G Metro, F Perrone, M Tiseo, M Bersanelli, ...
Clinical lung cancer 20 (4), 237-247. e1, 2019
422019
Countering countermeasures: detecting identity lies by detecting conscious breakthrough
H Bowman, M Filetti, A Alsufyani, D Janssen, L Su
PloS one 9 (3), e90595, 2014
322014
The cost of space independence in P300-BCI spellers
S Chennu, A Alsufyani, M Filetti, AM Owen, H Bowman
Journal of neuroengineering and rehabilitation 10 (1), 1-13, 2013
272013
Predictive biomarkers for checkpoint inhibitor-based immunotherapy: the galectin-3 signature in NSCLCs
C Capalbo, G Scafetta, M Filetti, P Marchetti, A Bartolazzi
International journal of molecular sciences 20 (7), 1607, 2019
222019
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death …
A Cortellini, M Bersanelli, D Santini, S Buti, M Tiseo, K Cannita, F Perrone, ...
European Journal of Cancer 128, 17-26, 2020
202020
Attention is more than prediction precision [Commentary on target article]
H Bowman, M Filetti, B Wyble, C Olivers
Behavioral and Brain Sciences 36 (3), 206-208, 2013
202013
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression≥ 50%: a multicenter study with external validation
A Cortellini, B Ricciuti, M Tiseo, E Bria, GL Banna, JGJV Aerts, F Barbieri, ...
Journal for immunotherapy of cancer 8 (2), 2020
152020
Immune-related adverse events of pembrolizumab in a large real-world cohort of patients with NSCLC with a PD-L1 expression≥ 50% and their relationship with clinical outcomes
A Cortellini, A Friedlaender, GL Banna, G Porzio, M Bersanelli, ...
Clinical Lung Cancer 21 (6), 498-508. e2, 2020
142020
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of≥ 50%
A Cortellini, M Tiseo, GL Banna, F Cappuzzo, JGJV Aerts, F Barbieri, ...
Cancer Immunology, Immunotherapy 69, 2209-2221, 2020
142020
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: case report and literature review
R Falcone, M Roberto, M Filetti, E Anselmi, P Marchetti
Medicine 97 (3), 2018
122018
Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition
C Capalbo, F Belardinilli, M Filetti, C Parisi, M Petroni, V Colicchia, ...
Molecular and clinical oncology 9 (1), 30-34, 2018
112018
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
O Nigro, G Pinotti, F De Galitiis, FR Di Pietro, R Giusti, M Filetti, ...
European Journal of Cancer 134, 19-28, 2020
102020
Breakthrough percepts of famous faces
A Alsufyani, O Hajilou, A Zoumpoulaki, M Filetti, H Alsufyani, CJ Solomon, ...
Psychophysiology 56 (1), e13279, 2019
102019
Latency as a region contrast: Measuring ERP latency differences with dynamic time warping
A Zoumpoulaki, A Alsufyani, M Filetti, M Brammer, H Bowman
Psychophysiology 52 (12), 1559-1576, 2015
102015
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden
D Marinelli, M Mazzotta, S Scalera, I Terrenato, F Sperati, L D'Ambrosio, ...
Annals of Oncology 31 (12), 1746-1754, 2020
92020
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer
C Capalbo, F Belardinilli, D Raimondo, E Milanetti, U Malapelle, ...
Cancers 11 (2), 147, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20